Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Orchestra BioMed (OBIO.US)$ The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5545 Views
Comment
Sign in to post a comment